Batusha Sopi, B.; Yonekawa, K.; Russmann, S.; Bernheim, J.; Caselli, S.; Schmied, C.; Hammer, H.; Lam, A.; Attenhofer Jost, C.
Cardiotoxicity Associated with Venlafaxine—Defining Features in a Series of Five Cases and a Call for Proactive Monitoring. J. Clin. Med. 2025, 14, 2792.
https://doi.org/10.3390/jcm14082792
AMA Style
Batusha Sopi B, Yonekawa K, Russmann S, Bernheim J, Caselli S, Schmied C, Hammer H, Lam A, Attenhofer Jost C.
Cardiotoxicity Associated with Venlafaxine—Defining Features in a Series of Five Cases and a Call for Proactive Monitoring. Journal of Clinical Medicine. 2025; 14(8):2792.
https://doi.org/10.3390/jcm14082792
Chicago/Turabian Style
Batusha Sopi, Bujana, Keiko Yonekawa, Stefan Russmann, Jasminka Bernheim, Stefano Caselli, Christian Schmied, Helene Hammer, Anna Lam, and Christine Attenhofer Jost.
2025. "Cardiotoxicity Associated with Venlafaxine—Defining Features in a Series of Five Cases and a Call for Proactive Monitoring" Journal of Clinical Medicine 14, no. 8: 2792.
https://doi.org/10.3390/jcm14082792
APA Style
Batusha Sopi, B., Yonekawa, K., Russmann, S., Bernheim, J., Caselli, S., Schmied, C., Hammer, H., Lam, A., & Attenhofer Jost, C.
(2025). Cardiotoxicity Associated with Venlafaxine—Defining Features in a Series of Five Cases and a Call for Proactive Monitoring. Journal of Clinical Medicine, 14(8), 2792.
https://doi.org/10.3390/jcm14082792
